Sun Pharmaceutical Industries Limited will hold a board meeting on Friday, October 30, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing. The trading window for the company's securities was closed on Thursday, October 1, 2026, and will remain closed until Sunday, November 1, 2026, following the results’ declaration.
